Drew McCormick
Head of Data & Analytics
Expertise:
Drew spearheads data strategy and organizational philosophy regarding data-driven insights across commercialization solutions. With more than a decade of experience investing and operating in Healthcare Information technology and Digital Life Sciences industries, he brings a unique perspective on innovative technologies and disruptive delivery models, with an ever-present goal to drive actionable and quantifiable impact.
With this experience, Drew leads EVERSANA’s data & analytics organization which leverages real world data across its various verticals – such as commercial analytics, advanced data science, field force effectiveness, and marketing analytics – to support the full spectrum of indications from rare & orphan diseases to chronic conditions.
Drew completed his undergraduate and master’s degree in Accounting from the University of Texas at Austin.
Articles by Drew McCormick
Navigating the Evolution of Precision Medicine: Data-Driven Strategies for Life Sciences Commercialization
The landscape of pharmaceutical commercialization has undergone a remarkable transformation over the past decade. Traditional blockbuster drugs, once the hallmark of the industry, have given way to other products such as targeted therapeutics designed for rare and orphan indications and oncology treatments. This shift toward precision medicine has had ripple effects across various domains, from clinical research to commercialization. In this new article by Drew McCormick, discover how manufacturers can deploy commercial strategies to maximize success for their new products and, most importantly, patient outcomes. Some topics discussed throughout the article include: Precision Medicine Paradigm Shift: The industry has witnessed a transition from broad-spectrum drugs (such as statins and TNF […]